The Proteasome Inhibitor Carfilzomib Functions Independently of P53 to Induce Cytotoxicity and an Atypical NF- B Response in Chronic Lymphocytic Leukemia Cells

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-2754
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

P53 and microRNAs in Chronic Lymphocytic Leukemia

Journal of Nucleic Acids Investigation
2011English

Functional Assessment of P53 in Chronic Lymphocytic Leukemia

Blood Cancer Journal
OncologyHematology
2011English

Chronic Lymphocytic Leukemia of the Bladder: An Atypical Etiology of Gross Hematuria

Therapeutic Advances in Urology
Urology
2014English

Fine Tuning of P53 Functions Between Normal and Leukemic Cells: A New Strategy for the Treatment of Chronic Lymphocytic Leukemia

Haematologica
Hematology
2019English

Signal-Dependent and Signal-Independent Functions of the B-Cell Receptor in Chronic Lymphocytic Leukemia

Haematologica
Hematology
2014English

Complement Dependent Cytotoxicity in Chronic Lymphocytic Leukemia: Ofatumumab Enhances Alemtuzumab Complement Dependent Cytotoxicity and Reveals Cells Resistant to Activated Complement

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2012English

Interdependent Regulation of P53 and miR-34a in Chronic Lymphocytic Leukemia

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2010English

Cd160 Expression in B Chronic Lymphocytic Leukemia (B-Cll.).

International Journal of Advanced Research
2017English

The Proteasome Inhibitor Bortezomib Interacts Synergistically With the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid to Induce T-Leukemia/Lymphoma Cells Apoptosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy